Treatment

AZD1613 - Part B clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1
Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
This study is looking at a new medicine called AZD1613 for adults with Polycystic Kidney Disease (ADPKD). It aims to check its safety, how well the body handles it, and if there are any side effects.
For: Autosomal Dominant Polycystic Kidney Disease
United States · China · United Kingdom